#News: We announced the completion of the acquisition of RayThera Inc. This acquisition marks another step in growing Biogen’s immunology portfolio, adding multiple potential assets for immune-mediated diseases. Read more: spr.ly/6012B1Dlmq
Official global newsroom account for Biogen, a leading biotech company pioneering innovative science since 1978. Community guidelines: bit.ly/1MZocKs
- We’re attending #GlomConHawaii to share more about our approach to C3G and primary IC-MPGN. Stop by booth #25 to learn how Biogen is working to transform care in complement-driven and immune-mediated kidney diseases.
- Today, we reported our Q2 results, demonstrating progress toward our goal of sustainable revenue growth. Read more: bit.ly/4yNFlUk Forward-looking statements: biogen.com/forward-lookin… #Earnings $BIIB
- #News: Today @synapticure announced its new ataxia care program. We’re proud to help support important awareness efforts as a part of our commitment to the broader ataxia communities. Read more: bit.ly/4vwPwtC

